Although our results suggest that SGLT2i use is associated with a lower PsA risk compared to GLP-1 RA, no significant difference was observed when comparing SGLT2i to DPP-4i
[17] When the can is three-quarters full, take it to your doctors office, a bio-hazard collection site, a hazardous waste center, or a syringe exchange program for disposal
Some employer-sponsored plans and certain commercial insurers have begun covering GLP-1 medications for weight loss, recognizing obesity as a chronic disease warranting treatment
Gender differences have emerged as well, with women reporting higher usage rates than men, particularly when weight management is the primary indication
Its best to focus on unsaturated (good) fats, which provide essential fatty acids (think: omega-3s), Pincus says